Doctors Without Borders: Third New TB Drug Developed in Z Half a Century Must Be Affordable
August 14, 2019
August 14, 2019
GENEVA, Switzerland, Aug. 14 -- The Doctors Without Borders/Medecins Sans Frontieres issued the following news:
GENEVA/NEW YORK - The US Food and Drug Administration (FDA) today approved a combination regimen containing a new drug, pretomanid, for the treatment of extensively drug-resistant tuberculosis (XDR-TB). As the third new drug developed for tuberculosis (TB) in over half a century, and the first to be developed as part of a ready-to-use treatment regimen, pretomanid's approv . . .
GENEVA/NEW YORK - The US Food and Drug Administration (FDA) today approved a combination regimen containing a new drug, pretomanid, for the treatment of extensively drug-resistant tuberculosis (XDR-TB). As the third new drug developed for tuberculosis (TB) in over half a century, and the first to be developed as part of a ready-to-use treatment regimen, pretomanid's approv . . .